ATLASDianthus Therapeutics (DNTH) earnings date: Nov 4, 2026
Dianthus Therapeutics (DNTH) reports earnings for the quarter ended Sep 30, 2026 on Wed, Nov 4, 2026. Analysts expect EPS of $1.00.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on DNTH
| Last price | $82.38 (-0.4%) |
|---|---|
| Normal 1-day range (±1σ) | ±3.0% |
| Earnings beat history | Beat the EPS estimate in 1 of the last 4 reports |
These figures come from the same calibrated model and valuation as the Dianthus Therapeutics stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Dianthus Therapeutics reports on Nov 4, 2026. One email the day before, with ATLAS’s read on Dianthus Therapeutics. You can switch it off at any time.
Alert me before DNTH reportsFree to start. Creating an account takes under a minute.
DNTH earnings at a glance
| Next report (confirmed) | Wed, Nov 4, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | $1.00 |
| Last report | Aug 4, 2026 · In line |
| Beat rate (last 4 reports) | 1 of 4 (25%) |
| Average EPS surprise | -7.3% |
| Average move around a report | ±10.8% (last 4) |
| Sector | Healthcare · Biotechnology |
Dianthus Therapeutics earnings history: last 4 reports
Dianthus Therapeutics last reported on Aug 4, 2026: EPS of -$0.90 against an estimate of -$0.91 (+1.1% surprise), in line with the estimate.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 4, 2026 | -$0.91 | -$0.90 | +1.1% | In line | +6.1% |
| May 5, 2026 | -$1.10 | -$0.85 | +22.7% | Beat | +1.2% |
| Apr 9, 2026 | -$0.07 | -$0.08 | -14.3% | Miss | +2.6% |
| Mar 9, 2026 | -$1.03 | -$1.43 | -38.8% | Miss | +33.3% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for DNTH
See the fair value, the probability range and the earnings history of Dianthus Therapeutics on its ATLAS page.
Dianthus Therapeutics (DNTH) stock analysisPlans from €3.99 a month.
Dianthus Therapeutics earnings: frequently asked questions
When does Dianthus Therapeutics (DNTH) report earnings?
Dianthus Therapeutics is scheduled to report on Wednesday, November 4, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for DNTH?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is $1.00 per share (USD). Estimates can change before the report.
How often does DNTH beat earnings estimates?
Of its last 4 reports with a recorded result, Dianthus Therapeutics beat the EPS estimate 1 times; the average surprise was -7.3%. Past results do not predict the next one.
How much does DNTH move around earnings?
Over its last 4 reports the stock moved an average of 10.8% (absolute, from the close before the report day to the close after it), and finished higher 4 of 4 times.
Did Dianthus Therapeutics beat earnings estimates last quarter?
Dianthus Therapeutics last reported on Aug 4, 2026: EPS of -$0.90 against an estimate of -$0.91 (+1.1% surprise), in line with the estimate.
How much does DNTH usually move in a day?
On a normal trading day the ATLAS model puts DNTH’s one-day range at about ±3.0%, with a 50% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Wed, Nov 4, 2026
Educational information, not investment advice. Disclaimer